STAT

NOVEMBER 20, 2024

Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company, founded in 1990, started out by making software that used the basic laws of physics to laboriously and exactly predict how molecules will interact with each other in space. Those calculations, rooted in the field of computational physics, needed lots of expensive and time-consuming computing power to run, and many people abandoned those t

139

139

Fierce Pharma

NOVEMBER 20, 2024

As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety findings” linked to the British drugmaker’s bleeding reversal agent.

FDA 131

FDA 131

STAT

NOVEMBER 20, 2024

WASHINGTON  — People close to Robert F. Kennedy Jr. are exploring a proposal that could upend how physician payment is determined in America, four sources familiar with the process told STAT.

145

145

Fierce Pharma

NOVEMBER 20, 2024

Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are already eying the blockbuster as a potential target. | The spinal muscular atrophy drug is a growth driver for the Swiss pharma giant, prompting the company to prioritize its defense against potential generics.

FDA 128

FDA 128

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

NOVEMBER 20, 2024

In 2016, the Arkansas Legal Aid Center was flooded with calls. People on a Medicaid program that provided in-home care assistance were having their caregiving hours cut. Reducing the hours for somebody with quadriplegia or cerebral palsy was devastating, said Kevin De Liban, an attorney with the organization at the time. “People are lying in their own waste, people are getting bed sores from not being turned.

137

137

Fierce Pharma

NOVEMBER 20, 2024

Johnson & Johnson and Merck are laying off workers in Chi | Johnson & Johnson and Merck are laying off workers in China, according to a story from Bloomberg which cites reports from Chinese news outlets.

128

128

Fierce Pharma

NOVEMBER 20, 2024

A bispecific antibody has entered the HER2 fray with a differentiated profile from traditional agents and a chance to challenge AstraZeneca and Daiichi Sankyo’s star antibody-drug conjugate Enhertu | A bispecific antibody has entered the HER2 fray with a differentiated profile from traditional agents and a chance to challenge AstraZeneca and Daiichi Sankyo’s star ADC Enhertu.

FDA 128

FDA 128

Pharmacy Times

NOVEMBER 20, 2024

Inflammation associated with asthma in children could perturb neurodevelopment.

121

121

Fierce Healthcare

NOVEMBER 20, 2024

The country’s largest pharmacy benefit managers and group purchasing organizations are going on offense against the Federal Trade Commission (FTC). | Major PBMs are countersuing the Federal Trade Commission, claiming the agency is biased and has too much authority to upend the industry.

119

119

STAT

NOVEMBER 20, 2024

When Randi Johnson was undergoing treatment for breast cancer, her husband, Brian, often felt at a loss to help. But then, when he and Randi met with a surgeon to discuss reconstructing her breast, he was struck by something he could do. The Midwestern father of five, a lifelong tinkerer, decided to make his wife the best possible prosthetic nipple.

117

117

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

NOVEMBER 20, 2024

It was only last October that UCB’s up-and-coming immunology powerhouse Bimzelx first crossed the FDA finish line in psoriasis after an initial delay. | The latest nod positions Bimzelx to go head-to-head with Novartis' Cosentyx in the hidradenitis suppurativa market.

FDA 114

FDA 114

STAT

NOVEMBER 20, 2024

Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties overseeing the company’s scientific and commercial efforts in cancer. Boshoff replaces Mikael Dolsten, who led research and development at the drug giant for 15 years and who announced his plans to retire in July.

114

114

pharmaphorum

NOVEMBER 20, 2024

Streamline claims management in the healthcare industry by eliminating swivel chair processes. Learn how healthcare providers and biopharma companies can optimise efficiency.

109

109

STAT

NOVEMBER 20, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning. Today, we meet Pfizer’s new chief scientific officer, ponder why the stock for Silence Therapeutics dropped despite promising data, and see that pharma executives aren’t too worried about Robert F.

113

113

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

NOVEMBER 20, 2024

Discover the latest treatments, clinical trials, and top healthcare professionals sharing insights on social media from the ESMO 2024 conference. Stay updated on the latest advancements in oncology.

108

108

Pharmacy Times

NOVEMBER 20, 2024

Lenora Newsome, PD, president of the National Association of Boards of Pharmacy, explores how pharmacists can support mental health.

107

107

pharmaphorum

NOVEMBER 20, 2024

Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease

105

105

Pharmacy Times

NOVEMBER 20, 2024

Vitamin D and calcium decreased systolic and diastolic blood pressure among older individuals with obesity.

106

106

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

NOVEMBER 20, 2024

MSD's subcutaneous formulation of top-selling cancer drug Keytruda was non-inferior to the current intravenous version in a head-to-head trial

105

105

Pharmaceutical Technology

NOVEMBER 20, 2024

The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for the third time.

102

102

pharmaphorum

NOVEMBER 20, 2024

The European Medicines Agency (EMA) has implemented a strategy to accelerate drug approvals in the EU. Learn more about their initiatives and how they are streamlining the process for faster access to medicines.

104

104

Pharmacy Times

NOVEMBER 20, 2024

If patterns and trends were to continue, the authors predict that nationwide overweight and obesity prevalence in adults will surpass 80% by 2050.

101

101

Drug Topics

NOVEMBER 20, 2024

A collection of hospitals in Rochester, New York, have teamed up to create better access to prescription drugs and combat the city’s pharmacy desert issue.

Hospitals 98

Hospitals 98

Pharmaceutical Technology

NOVEMBER 20, 2024

UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare Conference.

98

98

pharmaphorum

NOVEMBER 20, 2024

Discussions aimed at making AstraZeneca and Daiichi Sankyo's Enhertu available to breast cancer patients on the NHS have been abandoned

98

98

Pharmacy Times

NOVEMBER 20, 2024

Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.

FDA 97

FDA 97

pharmaphorum

NOVEMBER 20, 2024

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU

98

98

Fierce Healthcare

NOVEMBER 20, 2024

Should policymakers choose not to extend enhanced subsidies for Affordable Care Act (ACA) plans, about 4 million people would likely become uninsured, according to a new analysis. | Should policymakers choose not to extend enhanced subsidies for Affordable Care Act plans, about 4 million people would likely become uninsured, according to a new analysis.

92

92

Outsourcing Pharma

NOVEMBER 20, 2024

The global CDMO has entered into several high-value manufacturing deals this year.

86

86

STAT

NOVEMBER 20, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. And what better way to make the time fly than to keep busy.

Hospitals 82

Hospitals Pharmaceutical Companies Pharmaceutical Companies 82

Outsourcing Pharma

NOVEMBER 20, 2024

The global CDMO has entered into several high-value manufacturing deals this year.

86

86

Fierce Pharma

NOVEMBER 20, 2024

On the back of several strong quarters and a year already chock-full of manufacturing accords, Korean CDMO Samsung Biologics is adding yet another project to its contract manufacturing Rolodex. | Samsung Biologics said it inked a series of production pacts with an unnamed European pharma in a tie-up worth a total of $668 million. Samsung’s latest undertaking, which will see the CDMO provide manufacturing services to its client through 2031, brings the company’s cumulative new contract value this

81

81

Outsourcing Pharma

NOVEMBER 20, 2024

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of resilience and curiosity.

86

86